advanced search

Prefilled Syringes71

Issue No #71  October 10th, 2016


Download PDF


Inside the magazine

TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE
PREFILLED SYRINGES
Orfeo Niedermann
Ypsomed
TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE
Orfeo Niedermann provides insights into how connectivity enhances existing autoinjectors and adds value for users, physicians, pharma companies and insurers.
THE DEVELOPMENT OF THE MOLLY<sup>®</sup> PLATFORM
PREFILLED SYRINGES
SHL Medical
THE DEVELOPMENT OF THE MOLLY® PLATFORM
SHL Group explores the growth of the Molly® family of drug delivery devices as an example of how the auto injector market has changed over the last five years, and looks to the future.
NOVEL APPROACHES INCREASE PATIENT CONFIDENCE & DECREASE ANXIETY
PREFILLED SYRINGES
Joe Reynolds
Noble
NOVEL APPROACHES INCREASE PATIENT CONFIDENCE & DECREASE ANXIETY
Joe Reynolds introduces the latest approaches and technologies – such as needle simulators – to equip patients for confident, anxiety-free self administration of parenteral drugs.
RISK MITIGATION, PERFORMANCE & LARGER VOLUMES DRIVE INNOVATION
PREFILLED SYRINGES
Christa Janssen-Otten
West Pharmaceutical Services
RISK MITIGATION, PERFORMANCE & LARGER VOLUMES DRIVE INNOVATION
With a focus on the company’s Novapure® brand, Christa Janssen-Otten discusses the application of quality-by-design principles in the development of plungers for prefillable syringes and autoinjectors.
COMPANY SHOWCASE: NEMERA (INJECTABLES OFFERING)
PREFILLED SYRINGES
Adrien Tisserand
Nemera
COMPANY SHOWCASE: NEMERA (INJECTABLES OFFERING)
Nemera and its partners empower patients through good design with Nemera’s extensive experience in developing and manufacturing parenteral drug delivery devices. Its global centre of expertise comprises more than 60 engineers and experts in creative design and human factors activities.
A RISK MANAGEMENT APPROACH TO PREFILLED SYRINGE SELECTION FOR BIOTECHNOLOGY PRODUCTS
PREFILLED SYRINGES
Wendy Saffell-Clemmer
Baxter Biopharma Solutions
A RISK MANAGEMENT APPROACH TO PREFILLED SYRINGE SELECTION FOR BIOTECHNOLOGY PRODUCTS
Prefilled syringes are becoming an increasingly attractive option for complex biotechnology products, not least because of the savings in product volume compared to vials. There is now a wide range of options to suit different requirements which can make product selection a challenge. Wendy looks at what advances are currently being made.
LUBRICIOUS COATINGS TO REDUCE SILICONE OIL & PARTICLE LEVELS
PREFILLED SYRINGES
Bernd Zeiss
Gerresheimer
LUBRICIOUS COATINGS TO REDUCE SILICONE OIL & PARTICLE LEVELS
The market for prefilled syringes continues to grow as does the number of approved biologics delivered in this manner. Bernd Zeiss and Susan Dounce outline the results of a study using the combination of a Gx Baked-on RTF® syringe and the OmniflexCP® plunger.
ADDING COLOUR & FUNCTIONALITY TO PLASTICS USED IN MEDICAL DEVICES
EXPERT VIEW
Stephen Duckworth
ADDING COLOUR & FUNCTIONALITY TO PLASTICS USED IN MEDICAL DEVICES
Stephen Duckworth explains how – with an emphasis on the importance of complying with stringent and changing pharmaceutical regulations – advanced additives in plastics used to make drug delivery devices can significantly enhance the product.
PRODUCT SHOWCASE: SCHOTT’s SYRIQ<sup>®</sup> AND TOPPAC<sup>®</sup> RIGID CAPS
PREFILLED SYRINGES
Dr Folker Steden
SCHOTT
PRODUCT SHOWCASE: SCHOTT’s SYRIQ® AND TOPPAC® RIGID CAPS
Schott has added new closure systems to its already extensive portfolio of prefillable syringes. Offering more flexibility for pharma companies while keeping patients safe.
OPTIMUM PRIMARY PACKAGING STRATEGY: EARLY & HOLISTIC DEFINITION
PREFILLED SYRINGES
Dr Kate Hudson-Farmer
OPTIMUM PRIMARY PACKAGING STRATEGY: EARLY & HOLISTIC DEFINITION
Kate Hudson-Farmer and Niels Kure reveal conflicting pressures on the product development process in orphan indications which potentially lead to products in this category – especially emerging biotech products – being left with suboptimal drug delivery systems and primary packaging.
STERILISATION EFFECTS ON BIOPHARMACEUTICALS
PREFILLED SYRINGES
William Dierick
Terumo Pharmaceutical Solutions
STERILISATION EFFECTS ON BIOPHARMACEUTICALS
William Dierick and Koji Nakamura report studies comparing the effects of different sterilisation on the extractables and leachables content of biotherapeutic products in prefilled syringes.
THE MANDREL CHALLENGE
PREFILLED SYRINGES
Tamara McCartney
Avery Dennison LPM
THE MANDREL CHALLENGE
Tamara McCartney and Jos van Noort explain how the rigorous technical, regulatory and quality requirements of the pharmaceutical industry impact on labelling.
COMPANY SHOWCASE: MAXON MOTOR
INJECTION
Carsten Horn
Maxon Motor
COMPANY SHOWCASE: MAXON MOTOR
Medication delivery systems are vital for the survival of patients. New technologies and the expertise it takes to understand and use them are a must for designing absolute reliability into these systems, which will remove risk and reduce costs for hospitals and users alike.
CARTON PACKAGING SYSTEMS FOR PARENTERALS
PREFILLED SYRINGES
Christoph Hammer
Dividella
CARTON PACKAGING SYSTEMS FOR PARENTERALS
Set against the background of prefilled syringe and injection devices such as auto injectors as increasingly attractive presentations for both new and established parenteral pharmaceuticals, Christoph Hammer explores how innovative carton packaging solutions can enhance these presentations whilst meeting the stringent requirements of product protection.
PRODUCT SHOWCASE: PERFEXION™
INJECTION
Dr Folker Steden
SCHOTT
PRODUCT SHOWCASE: PERFEXION™
perfeXion™ is a new quality approach from Schottt, which controls every inch of pharma glass tubing and with its launch the company pushes towards a zero-defect philosophy in pharmaceutical glass tubing production.
PRODUCTIVE SUPPLY CHAIN SYNERGIES BETWEEN OMPI & BALDA
PREFILLED SYRINGES
Paul Wismer
SG Balda
PRODUCTIVE SUPPLY CHAIN SYNERGIES BETWEEN OMPI & BALDA
Alessandro Artioli, Alessandro Morandotti and Paul Wismer look at the first example of integration between Ompi and Balda since Balda's acquisition by Stevanato group: the Ompi EZ-fill® Integrated Tip Cap.
AUTOMATIC NEEDLE FEEDING & AUTOMATED PRODUCTION OF READY-TO-FILL PREFILLABLE SYRINGES
PREFILLED SYRINGES
Berthold Schopferer
Zahoransky
AUTOMATIC NEEDLE FEEDING & AUTOMATED PRODUCTION OF READY-TO-FILL PREFILLABLE SYRINGES
In this article, Harry Pruner describes the automated assembly equipment offered by ZAHORANSKY AG for the production of ready-to-fill, prefillable syringes.
Top